DrugPatentWatch Database Preview
Bacitracin zinc; polymyxin b sulfate - Generic Drug Details
Join the DrugPatentWatch Referral Program Get access to a free drug patent landscape report or a free one-month subscription
What are the generic drug sources for bacitracin zinc; polymyxin b sulfate and what is the scope of freedom to operate?
Bacitracin zinc; polymyxin b sulfate
is the generic ingredient in four branded drugs marketed by Glaxosmithkline, Akorn, Bausch And Lomb, Perrigo Co Tennessee, Pharmafair, Monarch Pharms, and Naska, and is included in seven NDAs. Additional information is available in the individual branded drug profile pages.There are twenty-seven drug master file entries for bacitracin zinc; polymyxin b sulfate. Seven suppliers are listed for this compound.
Summary for bacitracin zinc; polymyxin b sulfate
| US Patents: | 0 |
| Tradenames: | 4 |
| Applicants: | 7 |
| NDAs: | 7 |
| Drug Master File Entries: | 27 |
| Suppliers / Packagers: | 7 |
| Clinical Trials: | 1 |
| DailyMed Link: | bacitracin zinc; polymyxin b sulfate at DailyMed |
Recent Clinical Trials for bacitracin zinc; polymyxin b sulfate
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| National Institute of Allergy and Infectious Diseases (NIAID) | N/A |
| Glaxo Wellcome | N/A |
See all bacitracin zinc; polymyxin b sulfate clinical trials
Pharmacology for bacitracin zinc; polymyxin b sulfate
| Drug Class | Polymyxin-class Antibacterial |
| Physiological Effect | Decreased Cell Wall Synthesis & Repair |
US Patents and Regulatory Information for bacitracin zinc; polymyxin b sulfate
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Monarch Pharms | POLYSPORIN | bacitracin zinc; polymyxin b sulfate | OINTMENT;OPHTHALMIC | 061229-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | Start Trial | Start Trial | Start Trial | ||||
| Akorn | BACITRACIN ZINC AND POLYMYXIN B SULFATE | bacitracin zinc; polymyxin b sulfate | OINTMENT;OPHTHALMIC | 064028-001 | Jan 30, 1995 | AT | RX | No | No | Start Trial | Start Trial | Start Trial | |||
| Perrigo Co Tennessee | BACITRACIN ZINC AND POLYMYXIN B SULFATE | bacitracin zinc; polymyxin b sulfate | OINTMENT;OPHTHALMIC | 065022-001 | Feb 27, 2002 | AT | RX | No | No | Start Trial | Start Trial | Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Serving leading biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Major Patent Expirations 2019 - 2020
NCE-1 Patent Challenge Dates 2019 - 2020
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2019, www.DrugPatentWatch.com.